Every NSE & BSE company
5,771 listed companies, ranked by market cap. Open any company to see every announcement it has filed: order wins, results, earnings calls, fund raises, board meetings and more.
Sector
All sectors
Banking and Finance 627Commercial Services & Supplies 587General Industrials 482Textiles Apparels & Accessories 459Software & Services 314Cement and Construction 261Chemicals & Petrochemicals 260Metals & Mining 259Pharmaceuticals & Biotechnology 233Food, Beverages & Tobacco 230Realty 219Automobiles & Auto Components 216Consumer Durables 184FMCG 139Transportation 136Diversified Consumer Services 130Utilities 116Media 110Healthcare 99Retailing 93Hotels Restaurants & Tourism 85Oil & Gas 43Others 39Fertilizers 30Hardware Technology & Equipment 28Diversified 26Telecommunications Equipment 21Forest Materials 20Telecom Services 19
| # | Company | Sector | Market cap | Announcements | Latest |
|---|---|---|---|---|---|
| 12 | Sun Pharmaceutical Industries LtdNSE: SUNPHARMA · BSE: 524715 | Pharmaceuticals & Biotechnology | ₹4,32,864 Cr | 54 | Promoter Reclassification26 Sep 2026 |
| 35 | Divi's Laboratories LtdNSE: DIVISLAB · BSE: 532488 | Pharmaceuticals & Biotechnology | ₹2,53,523 Cr | 21 | Other Announcement26 Sep 2026 |
| 50 | Torrent Pharmaceuticals LtdNSE: TORNTPHARM · BSE: 500420 | Pharmaceuticals & Biotechnology | ₹1,81,512 Cr | 35 | Annual General Meeting7 Sep 2026 |
| 89 | Zydus Lifesciences LtdNSE: ZYDUSLIFE · BSE: 532321 | Pharmaceuticals & Biotechnology | ₹1,16,673 Cr | 68 | Business Update26 Sep 2026 |
| 95 | Laurus Labs LtdNSE: LAURUSLABS · BSE: 540222 | Pharmaceuticals & Biotechnology | ₹1,10,764 Cr | 38 | Earnings Call18 Sep 2026 |
| 100 | Cipla LtdNSE: CIPLA · BSE: 500087 | Pharmaceuticals & Biotechnology | ₹1,08,271 Cr | 44 | Employee Stock Options24 Sep 2026 |
| 109 | Mankind Pharma LtdNSE: MANKIND · BSE: 543904 | Pharmaceuticals & Biotechnology | ₹1,03,261 Cr | 50 | Annual General Meeting17 Sep 2026 |
| 115 | Dr. Reddy's Laboratories LtdNSE: DRREDDY · BSE: 500124 | Pharmaceuticals & Biotechnology | ₹1,00,829 Cr | 45 | Board Meeting Date22 Sep 2026 |
| 118 | Aurobindo Pharma LtdNSE: AUROPHARMA · BSE: 524804 | Pharmaceuticals & Biotechnology | ₹98,318 Cr | 63 | Regulatory Approval15 Sep 2026 |
| 123 | Lupin LtdNSE: LUPIN · BSE: 500257 | Pharmaceuticals & Biotechnology | ₹92,798 Cr | 57 | Employee Stock Options21 Sep 2026 |
| 167 | Glenmark Pharmaceuticals LtdNSE: GLENMARK · BSE: 532296 | Pharmaceuticals & Biotechnology | ₹65,222 Cr | 39 | Business Update23 Sep 2026 |
| 173 | Alkem Laboratories LtdNSE: ALKEM · BSE: 539523 | Pharmaceuticals & Biotechnology | ₹63,274 Cr | 49 | Management Change24 Sep 2026 |
| 181 | Biocon LtdNSE: BIOCON · BSE: 532523 | Pharmaceuticals & Biotechnology | ₹60,152 Cr | 57 | Business Update21 Sep 2026 |
| 189 | Abbott India LtdNSE: ABBOTINDIA · BSE: 500488 | Pharmaceuticals & Biotechnology | ₹55,493 Cr | 17 | Management Change7 Sep 2026 |
| 201 | Anthem Biosciences LtdNSE: ANTHEM · BSE: 544449 | Pharmaceuticals & Biotechnology | ₹50,144 Cr | 31 | Other Announcement21 Sep 2026 |
| 203 | Gland Pharma LtdNSE: GLAND · BSE: 543245 | Pharmaceuticals & Biotechnology | ₹49,604 Cr | 47 | Merger & Restructuring13 Sep 2026 |
| 204 | Ipca Laboratories LtdNSE: IPCALAB · BSE: 524494 | Pharmaceuticals & Biotechnology | ₹49,358 Cr | 20 | Earnings Call17 Aug 2026 |
| 219 | GlaxoSmithKline Pharmaceuticals LtdNSE: GLAXO · BSE: 500660 | Pharmaceuticals & Biotechnology | ₹46,671 Cr | 34 | Annual General Meeting15 Sep 2026 |
| 222 | Ajanta Pharma LtdNSE: AJANTPHARM · BSE: 532331 | Pharmaceuticals & Biotechnology | ₹44,653 Cr | 33 | Share Pledge18 Sep 2026 |
| 246 | Emcure Pharmaceuticals LtdNSE: EMCURE · BSE: 544210 | Pharmaceuticals & Biotechnology | ₹36,470 Cr | 47 | Earnings Call25 Sep 2026 |
| 251 | Wockhardt LtdNSE: WOCKPHARMA · BSE: 532300 | Pharmaceuticals & Biotechnology | ₹35,365 Cr | 28 | Legal & Regulatory25 Aug 2026 |
| 267 | Sai Life Science LtdNSE: SAILIFE · BSE: 544306 | Pharmaceuticals & Biotechnology | ₹33,097 Cr | 28 | Employee Stock Options18 Sep 2026 |
| 303 | Neuland Laboratories LtdNSE: NEULANDLAB · BSE: 524558 | Pharmaceuticals & Biotechnology | ₹28,104 Cr | 34 | Production Started15 Sep 2026 |
| 310 | Piramal Pharma LtdNSE: PPLPHARMA · BSE: 543635 | Pharmaceuticals & Biotechnology | ₹26,696 Cr | 32 | Other Announcement18 Sep 2026 |
| 313 | Rubicon Research LtdNSE: RUBICON · BSE: 544578 | Pharmaceuticals & Biotechnology | ₹26,432 Cr | 38 | Capital Structure Change16 Sep 2026 |
| 317 | Acutaas Chemicals LtdNSE: ACUTAAS · BSE: 543349 | Pharmaceuticals & Biotechnology | ₹25,844 Cr | 38 | Management Change26 Sep 2026 |
| 367 | Shilpa Medicare LtdNSE: SHILPAMED · BSE: 530549 | Pharmaceuticals & Biotechnology | ₹21,000 Cr | 46 | Share Pledge26 Sep 2026 |
| 373 | Granules India LtdNSE: GRANULES · BSE: 532482 | Pharmaceuticals & Biotechnology | ₹20,726 Cr | 41 | Promoter Buying25 Sep 2026 |
| 378 | Caplin Point Laboratories LtdNSE: CAPLIPOINT · BSE: 524742 | Pharmaceuticals & Biotechnology | ₹20,369 Cr | 25 | Annual General Meeting25 Sep 2026 |
| 409 | Pfizer LtdNSE: PFIZER · BSE: 500680 | Pharmaceuticals & Biotechnology | ₹17,623 Cr | 19 | Management Change18 Sep 2026 |
| 410 | OneSource Specialty Pharma LtdNSE: ONESOURCE · BSE: 544292 | Pharmaceuticals & Biotechnology | ₹17,612 Cr | 48 | Employee Stock Options25 Sep 2026 |
| 413 | Cohance Lifesciences LtdNSE: COHANCE · BSE: 543064 | Pharmaceuticals & Biotechnology | ₹17,485 Cr | 33 | Business Update21 Sep 2026 |
| 420 | Alivus Life Sciences LtdNSE: ALIVUS · BSE: 543322 | Pharmaceuticals & Biotechnology | ₹16,992 Cr | 23 | Merger & Restructuring16 Sep 2026 |
| 428 | Eris Lifesciences LtdNSE: ERIS · BSE: 540596 | Pharmaceuticals & Biotechnology | ₹16,436 Cr | 41 | Annual General Meeting25 Sep 2026 |
| 429 | Alembic Pharmaceuticals LtdNSE: APLLTD · BSE: 533573 | Pharmaceuticals & Biotechnology | ₹16,397 Cr | 65 | Debt & Borrowing25 Sep 2026 |
| 436 | Natco Pharma LtdNSE: NATCOPHARM · BSE: 524816 | Pharmaceuticals & Biotechnology | ₹16,157 Cr | 36 | Fund Raise25 Sep 2026 |
| 446 | Jubilant Pharmova LtdNSE: JUBLPHARMA · BSE: 530019 | Pharmaceuticals & Biotechnology | ₹15,756 Cr | 29 | Business Update11 Sep 2026 |
| 466 | AstraZeneca Pharma India LtdNSE: ASTRAZEN · BSE: 506820 | Pharmaceuticals & Biotechnology | ₹14,951 Cr | 42 | Legal & Regulatory18 Sep 2026 |
| 476 | Marksans Pharma LtdNSE: MARKSANS · BSE: 524404 | Pharmaceuticals & Biotechnology | ₹14,701 Cr | 30 | Promoter Selling (Off-Market)18 Sep 2026 |
| 477 | Syngene International LtdNSE: SYNGENE · BSE: 539268 | Pharmaceuticals & Biotechnology | ₹14,661 Cr | 38 | Management Change21 Sep 2026 |
| 488 | Concord Biotech LtdNSE: CONCORDBIO · BSE: 543960 | Pharmaceuticals & Biotechnology | ₹14,320 Cr | 27 | Bonus Issue23 Sep 2026 |
| 518 | Sudeep Pharma LtdNSE: SUDEEPPHRM · BSE: 544619 | Pharmaceuticals & Biotechnology | ₹13,084 Cr | 20 | Other Announcement22 Sep 2026 |
| 525 | Akums Drugs & Pharmaceuticals LtdNSE: AKUMS · BSE: 544222 | Pharmaceuticals & Biotechnology | ₹12,822 Cr | 35 | Other Announcement3 Sep 2026 |
| 539 | Corona Remedies LtdNSE: CORONA · BSE: 544644 | Pharmaceuticals & Biotechnology | ₹12,466 Cr | 22 | Capital Structure Change19 Sep 2026 |
| 581 | Viyash Scientific LtdNSE: VIYASH · BSE: 512529 | Pharmaceuticals & Biotechnology | ₹10,300 Cr | 46 | Employee Stock Options18 Sep 2026 |
| 592 | Strides Pharma Science LtdNSE: STAR · BSE: 532531 | Pharmaceuticals & Biotechnology | ₹10,035 Cr | 28 | Business Update11 Sep 2026 |
| 619 | Blue Jet Healthcare LtdNSE: BLUEJET · BSE: 544009 | Pharmaceuticals & Biotechnology | ₹9,335 Cr | 28 | Annual General Meeting21 Sep 2026 |
| 643 | Aarti Pharmalabs LtdNSE: AARTIPHARM · BSE: 543748 | Pharmaceuticals & Biotechnology | ₹8,841 Cr | 34 | Promoter Selling25 Sep 2026 |
| 644 | Procter & Gamble Health LtdNSE: PGHL · BSE: 500126 | Pharmaceuticals & Biotechnology | ₹8,808 Cr | 22 | Other Announcement18 Sep 2026 |
| 655 | Sanofi Consumer Healthcare India LtdNSE: SANOFICONR · BSE: 544250 | Pharmaceuticals & Biotechnology | ₹8,605 Cr | 17 | Financial Results28 Jul 2026 |
| 683 | Morepen Laboratories LtdNSE: MOREPENLAB · BSE: 500288 | Pharmaceuticals & Biotechnology | ₹7,888 Cr | 33 | Annual General Meeting26 Sep 2026 |
| 710 | Symbiotec Pharmalab LtdNSE: SYMBIOTEC · BSE: 544889 | Pharmaceuticals & Biotechnology | ₹7,386 Cr | 8 | Earnings Call22 Sep 2026 |
| 711 | Supriya Lifescience LtdNSE: SUPRIYA · BSE: 543434 | Pharmaceuticals & Biotechnology | ₹7,367 Cr | 28 | Annual General Meeting25 Sep 2026 |
| 719 | Bliss GVS Pharma LtdNSE: BLISSGVS · BSE: 506197 | Pharmaceuticals & Biotechnology | ₹7,193 Cr | 40 | Annual General Meeting22 Sep 2026 |
| 729 | Sanofi India LtdNSE: SANOFI · BSE: 500674 | Pharmaceuticals & Biotechnology | ₹7,017 Cr | 31 | Legal & Regulatory25 Sep 2026 |
| 757 | Innova Captab LtdNSE: INNOVACAP · BSE: 544067 | Pharmaceuticals & Biotechnology | ₹6,534 Cr | 31 | Other Announcement4 Sep 2026 |
| 774 | Senores Pharmaceuticals LtdNSE: SENORES · BSE: 544319 | Pharmaceuticals & Biotechnology | ₹6,395 Cr | 40 | Annual General Meeting25 Sep 2026 |
| 778 | Sun Pharma Advanced Research Company LtdNSE: SPARC · BSE: 532872 | Pharmaceuticals & Biotechnology | ₹6,390 Cr | 24 | Other Announcement20 Aug 2026 |
| 785 | IOL Chemicals and Pharmaceuticals LtdNSE: IOLCP · BSE: 524164 | Pharmaceuticals & Biotechnology | ₹6,308 Cr | 31 | Regulatory Approval23 Sep 2026 |
| 795 | Orchid Pharma LtdNSE: ORCHPHARMA · BSE: 524372 | Pharmaceuticals & Biotechnology | ₹6,028 Cr | 30 | Capital Structure Change23 Sep 2026 |
| 823 | Jeena Sikho Lifecare LtdNSE: JSLL · BSE: 544476 | Pharmaceuticals & Biotechnology | ₹5,485 Cr | 53 | Employee Stock Options23 Sep 2026 |
| 825 | FDC LtdNSE: FDC · BSE: 531599 | Pharmaceuticals & Biotechnology | ₹5,432 Cr | 28 | Annual General Meeting17 Sep 2026 |
| 853 | Gujarat Themis Biosyn LtdNSE: GUJTHEM · BSE: 506879 | Pharmaceuticals & Biotechnology | ₹5,076 Cr | 67 | Annual General Meeting21 Sep 2026 |
| 855 | Novartis India LtdNSE: NOVARTIND · BSE: 500672 | Pharmaceuticals & Biotechnology | ₹5,059 Cr | 34 | Annual General Meeting18 Sep 2026 |
| 885 | RPG Life Sciences LtdNSE: RPGLIFE · BSE: 532983 | Pharmaceuticals & Biotechnology | ₹4,851 Cr | 39 | Merger & Restructuring26 Sep 2026 |
| 923 | Zota Healthcare LtdNSE: ZOTA | Pharmaceuticals & Biotechnology | ₹4,428 Cr | 30 | Annual General Meeting21 Sep 2026 |
| 930 | Gufic BioSciences LtdNSE: GUFICBIO · BSE: 509079 | Pharmaceuticals & Biotechnology | ₹4,290 Cr | 33 | Legal & Regulatory24 Sep 2026 |
| 936 | SMS Pharmaceuticals LtdNSE: SMSPHARMA · BSE: 532815 | Pharmaceuticals & Biotechnology | ₹4,186 Cr | 25 | Other Announcement21 Sep 2026 |
| 961 | Aarti Drugs LtdNSE: AARTIDRUGS · BSE: 524348 | Pharmaceuticals & Biotechnology | ₹3,914 Cr | 30 | Management Change26 Sep 2026 |
| 964 | Kwality Pharmaceuticals LtdNSE: KPL · BSE: 539997 | Pharmaceuticals & Biotechnology | ₹3,892 Cr | 21 | Management Change2 Sep 2026 |
| 968 | Unichem Laboratories LtdNSE: UNICHEMLAB · BSE: 506690 | Pharmaceuticals & Biotechnology | ₹3,859 Cr | 24 | Business Update26 Sep 2026 |
| 1008 | Ind-Swift Laboratories LtdNSE: INDSWFTLAB · BSE: 532305 | Pharmaceuticals & Biotechnology | ₹3,482 Cr | 39 | Other Announcement25 Sep 2026 |
| 1032 | Solara Active Pharma Sciences LtdNSE: SOLARA · BSE: 541540 | Pharmaceuticals & Biotechnology | ₹3,281 Cr | 28 | Other Announcement26 Sep 2026 |
| 1047 | Shukra Pharmaceuticals LtdNSE: SHUKRAPHAR · BSE: 524632 | Pharmaceuticals & Biotechnology | ₹3,186 Cr | 28 | Annual General Meeting22 Sep 2026 |
| 1064 | Advanced Enzyme Technologies LtdNSE: ADVENZYMES · BSE: 540025 | Pharmaceuticals & Biotechnology | ₹3,058 Cr | 62 | Capital Structure Change25 Sep 2026 |
| 1101 | Hikal LtdNSE: HIKAL · BSE: 524735 | Pharmaceuticals & Biotechnology | ₹2,792 Cr | 28 | Annual General Meeting23 Sep 2026 |
| 1118 | Alembic LtdNSE: ALEMBICLTD · BSE: 506235 | Pharmaceuticals & Biotechnology | ₹2,696 Cr | 21 | Promoter Buying25 Sep 2026 |
| 1172 | Dishman Carbogen Amcis LtdNSE: DCAL · BSE: 540701 | Pharmaceuticals & Biotechnology | ₹2,408 Cr | 38 | Debt & Borrowing25 Sep 2026 |
| 1186 | Venus Remedies LtdNSE: VENUSREM · BSE: 526953 | Pharmaceuticals & Biotechnology | ₹2,335 Cr | 21 | Other Announcement7 Sep 2026 |
| 1188 | Sakar Healthcare LtdNSE: SAKAR | Pharmaceuticals & Biotechnology | ₹2,333 Cr | 24 | Other Announcement22 Sep 2026 |
| 1194 | Sai Parenterals LtdNSE: SAIPARENT · BSE: 544742 | Pharmaceuticals & Biotechnology | ₹2,310 Cr | 31 | Annual General Meeting10 Sep 2026 |
| 1200 | Indoco Remedies LtdNSE: INDOCO · BSE: 532612 | Pharmaceuticals & Biotechnology | ₹2,281 Cr | 33 | Other Announcement24 Sep 2026 |
| 1211 | Panacea Biotec LtdNSE: PANACEABIO · BSE: 531349 | Pharmaceuticals & Biotechnology | ₹2,225 Cr | 28 | Legal & Regulatory26 Sep 2026 |
| 1212 | Beta Drugs LtdNSE: BETA · BSE: 531481 | Pharmaceuticals & Biotechnology | ₹2,219 Cr | 27 | Business Update22 Sep 2026 |
| 1223 | Syncom Formulation (India) LtdNSE: SYNCOMF · BSE: 524470 | Pharmaceuticals & Biotechnology | ₹2,183 Cr | 22 | Other Announcement26 Sep 2026 |
| 1226 | Windlas Biotech LtdNSE: WINDLAS · BSE: 543329 | Pharmaceuticals & Biotechnology | ₹2,175 Cr | 33 | Earnings Call14 Aug 2026 |
| 1261 | Fredun Pharmaceuticals LtdNSE: FREDUN · BSE: 539730 | Pharmaceuticals & Biotechnology | ₹2,011 Cr | 31 | Capital Structure Change22 Sep 2026 |
| 1276 | NGL Fine - Chem LtdNSE: NGLFINE · BSE: 524774 | Pharmaceuticals & Biotechnology | ₹1,929 Cr | 23 | Legal & Regulatory25 Sep 2026 |
| 1296 | Hester Biosciences LtdNSE: HESTERBIO · BSE: 524669 | Pharmaceuticals & Biotechnology | ₹1,849 Cr | 24 | Promoter Reclassification4 Sep 2026 |
| 1351 | Fermenta Biotech LtdNSE: FERMENTA · BSE: 506414 | Pharmaceuticals & Biotechnology | ₹1,676 Cr | 29 | Other Announcement10 Sep 2026 |
| 1380 | Accent Microcell LtdNSE: ACCENTMIC | Pharmaceuticals & Biotechnology | ₹1,590 Cr | 20 | Capacity Expansion13 Aug 2026 |
| 1396 | Jagsonpal Pharmaceuticals LtdNSE: JAGSNPHARM · BSE: 507789 | Pharmaceuticals & Biotechnology | ₹1,541 Cr | 45 | Acquisition23 Sep 2026 |
| 1408 | Amrutanjan Health Care LtdNSE: AMRUTANJAN · BSE: 590006 | Pharmaceuticals & Biotechnology | ₹1,514 Cr | 33 | Annual General Meeting23 Sep 2026 |
| 1472 | Kopran LtdNSE: KOPRAN · BSE: 524280 | Pharmaceuticals & Biotechnology | ₹1,303 Cr | 28 | Price Movement Clarification22 Sep 2026 |
| 1486 | Bharat Parenterals LtdNSE: BPLPHARMA · BSE: 541096 | Pharmaceuticals & Biotechnology | ₹1,270 Cr | 28 | Board Meeting Date24 Sep 2026 |
| 1489 | Vikram Thermo (India) LtdNSE: VIKRAMTH · BSE: 530477 | Pharmaceuticals & Biotechnology | ₹1,257 Cr | 16 | Dividend4 Sep 2026 |
| 1528 | Lincoln Pharmaceuticals LtdNSE: LINCOLN · BSE: 531633 | Pharmaceuticals & Biotechnology | ₹1,157 Cr | 15 | Management Change24 Sep 2026 |
| 1534 | Sigachi Industries LtdNSE: SIGACHI · BSE: 543389 | Pharmaceuticals & Biotechnology | ₹1,142 Cr | 28 | Annual General Meeting15 Sep 2026 |
| 1568 | Bajaj Healthcare LtdNSE: BAJAJHCARE · BSE: 539872 | Pharmaceuticals & Biotechnology | ₹1,088 Cr | 31 | Annual General Meeting21 Sep 2026 |
| 1592 | Themis Medicare LtdNSE: THEMISMED · BSE: 530199 | Pharmaceuticals & Biotechnology | ₹1,045 Cr | 26 | Capital Structure Change24 Sep 2026 |